Lipitor keeps on selling, so Pfizer will keep on producing it in Ireland

It's official: Demand for the off-patent drug Lipitor has inspired Pfizer ($PFE) to keep an Irish plant it had slated for closure. Sales in emerging markets, and to a lesser extent the U.S., are behind the change of mind, which saves 160 jobs in Little Island, Cork. Improved productivity at the plant helped, too. Release | More

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.